Skip to main content
. 2021 Oct 13;13(20):5127. doi: 10.3390/cancers13205127
5-FU 5-fluorouracil
ADAM17 Adisintegrin and metalloproteinase 17
ALD Alcoholic liver disease
ALC Alcoholic liver cirrhosis
APC Antigen presenting cells
ARG1 Arginase 1
ATRA All-trans retinoic acid
CCL Chemokine (C-C motif) ligand
CCR CC motif chemokine receptors
CIK Cytokine-induced killer
COX2 Cyclooxygenase 2
CSF1/M-CSF Colony-stimulating factor 1
CSF1R Colony-stimulating factor 1 receptor
CXCL C-X-C motif ligand
DCs Dendritic cells
eMDSCs Early MDSCs
ENTPD2 Ectonucleoside triphosphate diphosphohydrolase 2
Gem Gemcitabine
GMP Gemcitabine monophosphate
HAIC Hepatic arterial infusion chemotherapy
HBV Hepatitis B virus
HCC Hepatocellular carcinoma
HCV Hepatitis C virus
HDACIs Histone deacetylase inhibitors
HSCs Hematopoietic stem cells
ICIs Immune-checkpoint inhibitors
IDO Indoleamine2,3-dioxygenase1
IL Multiple interleukins
IMCs Immature myeloid cells
LCP Lipid-coated calcium phosphate
LN L-selectin lymph node
LOX-1 Lectin-type oxidized LDL receptor 1
MDSCs Myeloid-derived suppressor cells
M-MDSCs Monocytic MDSCs
MPO Myeloperoxidase
NAFLD Non-alcoholic fatty liver disease
NO Nitric oxide
NOX2 NADPH oxidase
PDE5 Phosphodiesterase 5
PGE2 Prostaglandin E2
PMN-MDSCs Polymorphonuclear MDSCs
RIPK3 Receptor-interacting protein kinase 3
RNS Reactive nitrogen species
ROS Reactive oxygen
TAFs Tumor-associated fibroblasts
TAM2 M2-polarized tumor-associated macrophages
TLR2 Toll-like receptors 2
TIM3 T-cells immunoglobulin and mucin domain-containing protein 3
TIME Tumor immune microenvironment
TKIs Tyrosine kinase inhibitors
TNF-a Tumor necrosis factor-a
TRAIL-Rs TNF-related apoptosis-induced ligand receptors
Tregs Regulatory T cells